Estradiol and bisphenol A stimulate androgen receptor and estrogen receptor gene expression in fetal mouse prostate mesenchyme cells

Environmental Health Perspectives

Volumn 115, Issue 6, 2007, Pages 902-908

  Richter, Catherine A ^a   Taylor, Julia A ^a   Ruhlen, Rachel L ^a   Welshons, Wade V ^a   vom Saal, Frederick S ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

17 estradiol; Androgen receptor gene; Bisphenol A; Dose response relationship; Estrogen receptor I ( ) gene; Prostate; Sexual differentiation

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HYPOTHESIS; INHIBITION KINETICS; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MESODERM; MICE; PHENOLS; PROSTATE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34250343888     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9804     Document Type: Article

References (43)

1. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SMV. 2002. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 52:69-81.
2. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL. 2007. GenBank. Nucleic Acids Res 35:D21-D25.
3. Bustin SA. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169-193.
4. Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384.
5. Coser KR, Chesnes J, Hur JY, Ray S, Isselbacher KJ, Shioda T. 2003. Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100:13994-13999.
6. Cunha GR, Donjacour A. 1987. Stromal-epithelial interactions in normal and abnormal prostatic development. In: Current Concepts and Approaches to the Study of Prostate Cancer, Vol 239 (Coffey DS, Gardner WAJ, Bruchovsky N, Resnick MI, Karr JP, eds), New York:Alan R. Liss, Inc., 251-272.
7. Dodds EC, Lawson W. 1936. Synthetic oestrogenic agents without the phenanthrene nucleus. Nature 137:996.
8. Ellem SJ, Risbridger GP. 2006. Aromatase and prostate cancer. Minerva Endocrinol 31:1-12.
9. Grubbs FE. 1969. Procedures for detecting outlying observations in samples. Technometrics 11:1-21.
10. Gupta C. 1999. Modulation of androgen receptor (AR)-mediated transcriptional activity by EGF in the developing mouse reproductive tract primary cells. Mol Cell Endocrinol 152:169-178.
11. Gupta C. 2000. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 224:61-68.
12. Ho SM, Tang WY, Belmonte de Frausto JB, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632.
13. Institute of Laboratory Animal Resources. 1996. Guide for the Care and Use of Laboratory Animals. Washington, DC:National Academy Press.
14. Kirschenbaum A, Liu XH, Yao S, Narla G, Friedman SL, Martignetti JA, et al. 2006. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Carcinogenesis 27:216-224.
15. Kokontis JM, Liao S. 1999. Molecular action of androgen in the normal and neoplastic prostate. Vitam Harm 55:219-307.
16. Labarca C, Paigen K. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352.
17. Latil A, Bièche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, et al. 2001. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 61:1919-1926.
18. Marker PC, Donjacour AA, Dahiya R, Cunha GR. 2003. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174.
19. Montano MM, Welshons WV, vom Saal FS. 1995. Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats. Biol Reprod 53:1198-1207.
20. Nagel SC, Hagelbarger JL, McDonnell DP. 2001. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics. Endocrinology 142:4721-4728.
21. Nagel SC, vom Saal FS, Thayer KA, Dhar MD, Boechler M, Welshons WV. 1997. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105:70-76.
22. Prins GS, Birch L. 1995. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314.
23. Prins GS, Birch L, Greene GL. 1991. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199.
24. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson J-Å, et al. 1998. Estrogen receptor-β messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139:874-883.
25. Rajapakse N, Silva E, Kortenkamp A. 2002. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110:917-921.
26. Rajfer J, Coffey DS. 1978. Sex steroid imprinting of the immature prostate. Invest Urol 16:186-190.
27. Richter CA, Timms BE, vom Saal FS. 2005. Prostate development: mechanisms for opposite effects of low and high doses of estrogenic chemicals. In: Endocrine Disruptors: Effects on Male and Female Reproductive Systems (Naz RK, ed). New York:CRC Press, 379-410.
28. Risbridger GP, Almahbobi GA, Taylor RA. 2005. Early prostate development and its association with late-life prostate disease. Cell Tissue Res 322:173-181.
29. Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ. 2003. Oestrogens and prostate cancer. Endocr Relat Cancer 10:187-191.
30. Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in human maternal-fetal-placental unit. Environ Health Perspect 110:A703-A707.
31. Shioda T, Chesnes J, Coser KR, Zou L, Hur J, Dean KL, et al. 2006. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci USA 103:12033-12038.
32. Takao Y, Lee HC, Kohra S, Arizono K. 2002. Release of bisphenol A from food can lining upon heating, J Health Sci 48:331-334.
33. Thayer KA, Ruhlen RL, Howdeshell KL, Buchanan DL, Cooke PS, Preziosi D, et al. 2001. Altered prostate growth and daily sperm production in male mice exposed prenatally to sub-clinical doses of 17α-ethinyl oestradiol. Hum Reprod 16:988-996.
34. Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS. 2005. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 102:7014-7019.
35. Timms BG, Mohs TJ, Didio LJA. 1994. Ductal budding and branching patterns in the developing prostate. J Urol 151:1427-1432.
36. Timms BG, Petersen SL, vom Saal FS. 1999. Prostate gland growth during development is stimulated in both male and female rat fetuses by intrauterine proximity to female fetuses. J Urol 161:1694-1701.
37. vom Saal FS, Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113:926-933.
38. vom Saal FS, Quadagno DM, Even MD, Kaisler LW, Keisler DH, Khan S. 1990. Paradoxical effects of maternal stress on fetal steroid and postnatal reproductive traits in female mice from different intrauterine positions. Biol Reprod 43:751-761.
39. vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al. 1997. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056-2061.
40. vom Saal FS, Welshons WV. 2006. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100:50-76.
41. Welshons WV, Nagel SC, Thayer KA, Judy BM, vom Saal FS. 1999. Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice. Toxicol Ind Health 15:12-25.
42. Welshons WV, Nagel SC, vom Saal FS. 2006. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69.
43. Woodham C, Birch L, Prins GS. 2003. Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology 144:4841-4850.